Tvaster Genkalp

3B Blackbio Dx LimitedMedical DevicesIndia

69% matchPublic

3B BlackBio Dx Limited is a biotechnology research and diagnostic solutions company based in Bhopal, Madhya Pradesh, India, providing molecular solutions for oncology and infectious diseases.

AnchorDxMedical DeviceChina

65% match

AnchorDx is a public biotechnology company headquartered in Guangzhou, China, with additional research and production facilities in the United States. The company specializes in the development of advanced cancer screening and early diagnostic solutions utilizing genomic and molecular technologies. Their products target precision medicine and oncology markets globally.

Amplifold AI Private Limited is an Indian company based in Bangalore that is developing DNA-origami-enabled signal amplification technology for rapid diagnostics.

CelLBxHealth plc, formerly known as ANGLE plc until its name change in October 2025, is a medical diagnostics enterprise established in 1994 and headquartered in Guildford, United Kingdom. The company is dedicated to developing advanced cancer diagnostic products, serving markets across the United Kingdom, Europe, North America, and other international regions. Its core offerings include the Parsortix PC1 and PR1 systems, which are innovative medical devices engineered to capture and retrieve intact circulating tumor cells (CTCs) from patient blood. Specifically, the PC1 system is designed for metastatic breast cancer samples, facilitating subsequent user-validated downstream analysis. CelLBxHealth also provides the Portrait+ CTC Staining kit, a laboratory solution for the identification, characterization, and enumeration of epithelial and mesenchymal CTCs with high analytical sensitivity and specificity, alongside the CellKeep Slide technology for CTC harvesting. In addition to these products, the company delivers a suite of laboratory services, including CTC enrichment and liquid biopsy analysis. Specialized assays are also available, such as Portrait Flex for immunofluorescence-based identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition, Portrait PD-L1 for CTC evaluation, and bespoke custom CTC assays. Furthermore, CelLBxHealth plc has forged strategic alliances, including a partnership with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. for the application of its pan-cancer next-generation sequencing (NGS) panel.

Genomictree Inc.Biotech, Medical DevicesSouth Korea

61% match

Genomictree Inc. is a healthcare sector company headquartered in Daejeon, South Korea, founded in 2000. The company focuses on developing products like the EarlyTect colon cancer screening test.

INOVIQ LTDIIQ · Health Care Equipment & ServicesNotting Hill, Australia

61% matchPublic

INOVIQ Ltd specializes in the research, development, and commercialization of diagnostic and exosome-based products, aiming to improve the detection and treatment of cancer and other conditions across Australia and the United States. Its current portfolio includes the hTERT test, an immunocytochemistry assay that serves as a supplementary tool for urine cytology in bladder cancer screening, alongside EXO-NET, designed for the capture and isolation of exosomes from liquid biopsy specimens. The company also boasts a robust diagnostic pipeline, featuring blood tests currently under development for various cancers, including ovarian and breast cancer. Originally incorporated in 1983 and formerly known as BARD1 Life Sciences Limited until its rebranding to INOVIQ Ltd in December 2021, the company maintains its headquarters in Notting Hill, Australia.